Who is sponsoring NCT03258996?

NCT03258996 is sponsored by Aitziber Fernandez Jimenez.

What condition does NCT03258996 study?

NCT03258996 studies Gingival Recessions.

Is NCT03258996 still recruiting?

NCT03258996 is currently completed. Last updated 8 March 2022.

Last reviewed 2022-03-08 · How we verify

NCT03258996

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

m-VISTA Technique vs. CAF in the Treatment of Class III Multiple Recessions

Completed NA Last updated 8 March 2022

What this trial tests

NA trial testing Modified vestibular incision subperiosteal tunnel access in Gingival Recessions in 24 participants. Completed in 30 September 2021.

Timeline

4 December 2017

Primary endpoint
31 March 2021

30 September 2021

Quick facts

Lead sponsor	Aitziber Fernandez Jimenez
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	24
Start date	4 December 2017
Primary completion	31 March 2021
Estimated completion	30 September 2021
Sites	1 location across Spain

Drugs / interventions tested

Modified vestibular incision subperiosteal tunnel access
Coronally advanced flap

Conditions studied

Gingival Recessions — all drugs for Gingival Recessions →

Sponsor

Aitziber Fernandez Jimenez

Who can join

18 and older, any sex, with Gingival Recessions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective is to assess whether the percentage of root coverage (%RC) achieved in the treatment of multiples class III recessions using the technique we have called modified vestibular incision subperiosteal tunnel access (m-VISTA), which is a lateral approach subperiosteal tunnel technique, combined with a connective tissue graft is greater than that achieved through the coronally advance flap (CAF) technique together with a connective tissue graft.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Description of the modified vestibular incision subperiosteal tunnel access (m-VISTA) technique in the treatment of multiple Miller class III gingival recessions: a case series.
Fernández-Jiménez A, Estefanía-Fresco R, García-De-La-Fuente AM, Marichalar-Mendia X, et al · · 2021 · cited 13× · PMID 33743644 · DOI 10.1186/s12903-021-01511-5
Comparative study of the modified VISTA technique (m-VISTA) versus the coronally advanced flap (CAF) in the treatment of multiple Miller class III/RT2 recessions: a randomized clinical trial.
Fernández-Jiménez A, Estefanía-Fresco R, García-De-La-Fuente AM, Marichalar-Mendia X, et al · · 2023 · cited 8× · PMID 36264343 · DOI 10.1007/s00784-022-04746-w
Importance of pain perception after mucogingival surgery in multiple Miller class III/RT2 gingival recessions: A randomized clinical trial.
Fernández-Jiménez A, García-De-La-Fuente AM, Estefanía-Fresco R, Lafuente-Ibañez-de-Mendoza I, et al · · 2025 · PMID 39724526 · DOI 10.4317/medoral.26906

Verify or expand the search:

Other recruiting trials for Gingival Recessions

Currently open trials in the same condition.

NCT07523802 — Management of Postoperative Pain Following Free Gingival Graft Harvesting Using Ora-Aid Versus Acrylic Palatal Stent · NA · recruiting
NCT07158528 — Comparing CAF and TCAF With Soft Tissue Grafting for Treating Multiple Recessions in the Maxilla. · NA · recruiting
NCT06940050 — Comparing CAF and TCAF With Soft Tissue Grafting for Treating Multiple Recessions in the Premandibula. · NA · recruiting
NCT06603467 — Guided Versus Non-Guided Harvesting Technique of Soft Tissue Graft in Cairo Recession Type I Sites · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03258996 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aitziber Fernandez Jimenez
Last refreshed: 8 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03258996.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing